Nosocomial clusters of fungal infections, whilst uncommon, cannot be predicted and are
associated with significant morbidity and mortality. Here, we review reports of nosocomial …

Background The emerging fungal pathogen Candida auris poses a serious threat to global
public health due to its worldwide distribution, multidrug resistance, high transmissibility …

ABSTRACT Introduction Invasive Candida Infections (ICIs) have undergone a series of
significant epidemiological, pathophysiological, and clinical changes during the last …

Although the Vitek 2 system is broadly used for antifungal susceptibility testing of Candida
spp., its performance against Candida auris has been assessed using limited number of …

Background The emerging fungal pathogen Candida auris poses a serious threat to global
public health due to its worldwide distribution, multidrug-resistance, high transmissibility …

Background Candida auris is an emerging yeast pathogen that can cause invasive
infections, particularly candidemia, in healthcare settings. Candida auris is characterized by …

Invasive fungal infection (IFI) is a significant global healthcare concern among critically ill
and immunocompromised patients. In Middle Eastern countries, IFI has been steadily …

Introduction The Centers for Disease Prevention and Control lists Candida auris, given its
global emergence, multidrug resistance, high mortality, and persistent transmissions in …

Mucormycoses are emerging fungal infections caused by a variety of heterogeneous
species within the Mucorales order. Among the Mucor species complex, Mucor circinelloides …

The global rate of Amphotericin B (AmB) resistance in Candida auris has surpassed 12%.
However, there is limited data on available clinical treatments and microevolutionary …